Abbott
ABT
$1.46 (1.26%)
1D
1W
3M
1Y
5Y
ALL
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 5 days ago • ABT
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 YearsThe Motley Fool • 11 days ago • ABT
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold ForeverZacks Investment Research • 12 days ago • ABT
PAHC or ABT: Which Is the Better Value Stock Right Now?Accesswire • 12 days ago • ABT
Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches InvestigatesReuters • 12 days ago • ABT
Abbott India posts Q2 profit rise on strong demand, price hikesCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.